New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy

Diabetic nephropathy (DN) is a severe complication of diabetes and serves as the leading cause of chronic renal failure. In the past decades, angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin II receptor blockers (ARBs) based first-line therapy can slow but cannot stop the progression of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Zhanjun, Sun, Ying, Yang, Guangrui, Zhang, Aihua, Huang, Songming, Heiney, Kristina Marie, Zhang, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927865/
https://www.ncbi.nlm.nih.gov/pubmed/24624137
http://dx.doi.org/10.1155/2014/818530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927865/
https://www.ncbi.nlm.nih.gov/pubmed/24624137
http://dx.doi.org/10.1155/2014/818530

Ejemplares similares